test

Scott Smith

@Acuta Capital Partners, Llc

Latest period2024 - Q3ReportedManaged Assets$123.464MTotal holdings41
Assets growth rate3.99%Assets growth rate (2-Q avg)-9.44%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Acuta Capital Partners, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 41 positions.

Assets under management

The assets under management (AUM) of Acuta Capital Partners, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 123.464M in assets, with a quarterly growth rate of 3.99% and a 2-quarter average growth rate of -9.44%. The portfolio is managed by Scott Smith, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
SRPTSarepta Therapeutics Inc
Recent Activity
Exited
0%
$4.345M
27,500 shares@ $158.0 avg price
AGIOAgios Pharma
Recent Activity
Exited
0%
$3.394M
78,700 shares@ $43.12 avg price
VRDNViridian Therapeutics Inc
Recent Activity
Exited
0%
$2.595M
199,433 shares@ $13.01 avg price
ORICOric Pharmaceuticals Inc
Recent Activity
Exited
0%
$678,720
96,000 shares@ $7.07 avg price
PLRXPliant Therapeutics Inc
Recent Activity
Exited
0%
$496,650
46,200 shares@ $10.75 avg price
NAMSNewamsterdam Pharma Co Nv
Recent Activity
Exited
0%
$432,225
22,500 shares@ $19.21 avg price
CLRBCellectar Biosciences Inc.
Recent Activity
Exited
0%
$176,250
70,500 shares@ $2.5 avg price
SVRASavara Inc
Recent Activity
Exited
0%
$100,750↓ Put
250 shares@ $403.0 avg price